NEWAMSTERDAM PHARMA COMPANY NV Share Price Today: Live Updates & Key Insights

NEWAMSTERDAM PHARMA COMPANY NV share price today is $28.9, up -4.99%. The stock opened at $30.75 against the previous close of $30.46, with an intraday high of $31.175 and low of $28.895.

NEWAMSTERDAM PHARMA COMPANY NV Share Price Chart

NEWAMSTERDAM PHARMA COMPANY NV

us-stock
To Invest in {{usstockname}}
us-stock

NEWAMSTERDAM PHARMA COMPANY NV Share Price Performance

$28.9 -0.0499(-4.99%) NAMS at 23 Mar 2026 02:25 PM Biotechnology
Lowest Today 28.895
Highest Today 31.175
Today’s Open 30.75
Prev. Close 30.46
52 Week High 42.00
52 Week Low 14.06
Day’s Range: Low 28.895 High 31.175
52-Week Range: Low 14.06 High 42.00
1 day return -
1 Week return -2.85
1 month return -19.83
3 month return -20.75
6 month return +6.86
1 year return +20.58
3 year return +116.94
5 year return +192.32
10 year return -

NEWAMSTERDAM PHARMA COMPANY NV Institutional Holdings

Frazier Life Sciences Management, L.P. 14.74

Capital World Investors 8.68

RA Capital Management, LLC 8.31

FCPM III SERVICES BV 8.01

American Funds SMALLCAP World A 7.48

Bain Capital Life Sciences Investors, LLC 6.35

FMR Inc 5.58

Wellington Management Company LLP 4.38

Viking Global Investors LP 3.66

Deerfield Management Co 3.62

Vanguard Health Care Inv 3.19

Jennison Associates LLC 3.03

Duquesne Family Office LLC 2.67

Medicxi Ventures Management (Jersey) Ltd 2.50

Polar Capital Holdings PLC 2.41

JPMorgan Chase & Co 2.27

Capital Group Global Equity Canada F 2.19

Polar Capital Biotech S Inc 2.17

Cormorant Asset Management, LLC 1.89

AllianceBernstein L.P. 1.86

HHG PLC 1.84

Capital Research & Mgmt Co - Division 3 1.79

Maverick Capital Ltd 1.65

Morgan Stanley - Brokerage Accounts 1.30

Fidelity Contrafund 1.04

Jennison SMid Cap Core Equity 0.84

PGIM Jennison Small Company A 0.84

Candriam Eqs L Biotech C USD Cap 0.60

American Funds New Economy A 0.58

Capital Group New Economy Comp 0.58

Fidelity Select Health Care 0.58

Fidelity Advisor Biotechnology I 0.51

iShares Biotechnology ETF 0.49

Fidelity Select Biotechnology 0.49

Jennison Health Sciences Equity 0.46

PGIM Jennison Health Sciences Z 0.46

BNP Paribas Health Cr Innovtr Cl Cap 0.45

Fidelity Small Cap Growth 0.44

JPMorgan Small Cap Growth A 0.41

Pictet-Biotech P USD 0.41

NEWAMSTERDAM PHARMA COMPANY NV Market Status

Strong Buy: 5

Buy: 4

Hold: 0

Sell: 0

Strong Sell: 0

NEWAMSTERDAM PHARMA COMPANY NV Fundamentals

Market Cap 3327.39 M

PB Ratio 5.1244

PE Ratio 0.0

Enterprise Value 2866.11 M

Total Assets 769.28 M

Volume 909348

NEWAMSTERDAM PHARMA COMPANY NV Company Financials

Annual Revenue FY25:22503000 22.5M, FY24:45563000 45.6M, FY23:14090000 14.1M, FY22:97500000 97.5M, FY21:0 0.0M

Annual Profit FY25:22444000 22.4M, FY24:45563000 45.6M, FY23:14045606 14.0M, FY22:97500000 97.5M, FY21:null 0.0M

Annual Net worth FY25:-203819000 -203.8M, FY24:null 0.0M, FY23:-176937000 -176.9M, FY22:-148884000 -148.9M, FY21:-28815000 -28.8M

Quarterly Revenue Q4/2025:32000 0.0M, Q3/2025:348000 0.3M, Q2/2025:19145000 19.1M, Q1/2025:2978000 3.0M, Q3/2024:29111000 29.1M

Quarterly Profit Q4/2025:-27000 -0.0M, Q3/2025:348000 0.3M, Q2/2025:19145000 19.1M, Q1/2025:2978000 3.0M, Q3/2024:29111000 29.1M

Quarterly Net worth Q4/2025:-74923000 -74.9M, Q3/2025:-72005000 -72.0M, Q2/2025:-17364000 -17.4M, Q1/2025:-39527000 -39.5M, Q3/2024:-16647000 -16.6M

About NEWAMSTERDAM PHARMA COMPANY NV & investment objective

Company Information NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with cardiometabolic disease. It is developing Obicetrapib, an oral low-dose cholesteryl ester transfer protein (CETP) inhibitor, that is in various clinical trials as a monotherapy and a combination therapy with ezetimibe for lowering LDL-C for cardiovascular diseases. The company also develops Obicetrapib which is in Phase 2a clinical trial for Alzheimer's disease. NewAmsterdam Pharma Company N.V. is headquartered in Naarden, the Netherlands.

Organisation Biotechnology

Employees 100

Industry Biotechnology

CEO Dr. Michael Harvey Davidson FACC, Facp., M.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

NEWAMSTERDAM PHARMA COMPANY NV FAQs

What is the share price of NEWAMSTERDAM PHARMA COMPANY NV today?

The current share price of NEWAMSTERDAM PHARMA COMPANY NV is $28.9.

Can I buy NEWAMSTERDAM PHARMA COMPANY NV shares in India?

Yes, Indian investors can buy NEWAMSTERDAM PHARMA COMPANY NV shares by opening an international trading and demat account with Motilal Oswal.

How to buy NEWAMSTERDAM PHARMA COMPANY NV shares in India?

You can easily invest in NEWAMSTERDAM PHARMA COMPANY NV shares from India by:

Can I buy fractional shares of NEWAMSTERDAM PHARMA COMPANY NV?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of NEWAMSTERDAM PHARMA COMPANY NV?

NEWAMSTERDAM PHARMA COMPANY NV has a market cap of $3327.39 M.

In which sector does NEWAMSTERDAM PHARMA COMPANY NV belong?

NEWAMSTERDAM PHARMA COMPANY NV operates in the Biotechnology sector.

What documents are required to invest in NEWAMSTERDAM PHARMA COMPANY NV stocks?

To invest, you typically need:

What is the PE and PB ratio of NEWAMSTERDAM PHARMA COMPANY NV?

The PE ratio of NEWAMSTERDAM PHARMA COMPANY NV is N/A and the PB ratio is 5.12.